CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Artimplant AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Artimplant AB
Hulda Mellgrens gata 5, Vastra Frolunda
Phone: +46 317465600p:+46 317465600 GOTEBORG, 421 32  Sweden Ticker: ARTI BARTI B

Filed for Bankruptcy on 8/1/2013
Filed in the District Court of Gothenburg
This company is no longer actively traded on any major stock exchange.

Business Summary
Artimplant AB is a Sweden-based medical device company. It is active in the development, production and marketing of degradable implants for the regeneration of body functions. Its products are made from the biomaterial called Artelon. Artimplant AB’s implants are mainly used for the treatment of osteoarthritis and the reinforcement of weakened soft tissue. The Company’s business portfolio includes such products as Artelon Tissue Reinforcement, Artelon CMC Spacer, Artelon CMC Soft, Artelon MTP Spacer and Artelon MTP Soft, among others. It distributes its products primarily in the United States and Europe through global and regional license agreements, original equipment manufacturer (OEM) agreements, country-specific distribution agreements, as well as direct sales via agents. As of December 31, 2011, Artimplant AB was the Parent Company of the Artimplant Group, which also had operations through its wholly-owned subsidiary, Artimplant USA, Inc. In August 2013, it filed for bankruptcy.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201312/31/2012Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board HakanJohansson 58 6/28/2013 5/4/2010
Chief Executive Officer, President KjellThornbring 55 6/28/2011 1/1/2011
Chief Financial Officer SusanLinke 44 6/28/2011 6/28/2011
7 additional Officers and Directors records available in full report.

Business Names
Business Name
APLTF
ARTI B
ARTI-B
Artimplant Group

General Information
Number of Employees: 17 (As of 3/31/2013)
Outstanding Shares: 513,982,256 (As of 3/31/2013)
Shareholders: 7,597
Stock Exchange: STO
Fax Number: +46 317465660


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023